Table 2.
Prevalence of Leishmania infection among suspected VL patients
| Suspected VL patients | |||
|---|---|---|---|
| Variable | N-positive/ N-tested | % (+ve) | P Value Fisher exact test |
| Gender | 0.525 | ||
| Male | (7/23) | 30.0 | |
| Female | (3/7) | 42.9 | |
| Age groups | 0.188 | ||
| < 15 years | (7/11) | 63.6 | |
| 15–44 years | (1/12) | 8.3 | |
| > 45 years | (2/7) | 28.1 | |
| Nationality | 0.102 | ||
| Saudi | (5/22) | 22.7 | |
| Non-Saudi | (5/8) | 62.5 | |
| Splenomegaly | 0.077 | ||
| Absent | (0/7) | 0 | |
| Present | (10/23) | 45 | |
| L. Node Enlargement | 0.142 | ||
| Absent | (0/20) | 0 | |
| Present | (3/10) | 33.3 | |
| Overall | (10/30) | 33.3 | |
VL = visceral leishmaniasis.